Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Sunitinib Before and After Surgery in Treating Patients With Stage IV Kidney Cancer
The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2009
by National Cancer Institute (NCI).
Recruitment status was Recruiting
Study NCT00717587 Information provided by National Cancer Institute (NCI)
First Received on July 16, 2008. Last Updated on January 15, 2011
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Kidney Cancer
Additional conditions recognized in this trial
Carcinoma, Renal Cell
Kidney Neoplasms
More general conditions related to this trial
Adenocarcinoma
Carcinoma
Kidney Diseases
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Urogenital Neoplasms
Urologic Diseases
Urologic Neoplasms
Interventions listed in this trial
motexafin gadolinium
sunitinib malate
comparative genomic hybridization
gene expression analysis
mutation analysis
polymorphism analysis
iodine I-124 girentuximab
laboratory biomarker analysis
pharmacological study
adjuvant therapy
neoadjuvant therapy
therapeutic conventional surgery
Additional drug interventions recognized in this trial
Sunitinib
More general drug interventions related to this trial
Angiogenesis Inhibitors
Angiogenesis Modulating Agents
Antineoplastic Agents
Dermatologic Agents
Growth Inhibitors
Growth Substances
Pharmacologic Actions
Photosensitizing Agents
Physiological Effects of Drugs
Radiation-Sensitizing Agents
Therapeutic Uses
Sponsors listed in this trial
Abramson Cancer Center of the University of Pennsylvania
National Cancer Institute (NCI)
Back to top of Main Content
